Cynosure's proprietary aesthetic laser systems receive regulatory approvals in Asia and South America

Cynosure, Inc., (Nasdaq: CYNO) today announced four international regulatory approvals that extend the reach of the company's proprietary aesthetic laser systems in Asia and South America.  

Elite MPX™, Cynosure's unique dual-wavelength platform for an array of aesthetic applications, was approved for marketing in Korea.  Elite MPX and the Elite™ Aesthetic Workstation, which combines two wavelengths for safe and effective laser hair removal on virtually any skin type, were awarded marketing authorization in Colombia.   Smartlipo MPX™, one of the newest members of Cynosure's award-winning family of LaserBodySculpting(SM) workstations, received approval in Hong Kong.  The company maintains a direct sales office in Korea and distributor relationships in Colombia and Hong Kong.

Including the products covered by today's announcement, four of Cynosure's flagship products are marketed in Colombia, five are sold in Korea and eight in Hong Kong.  

"Overseas markets represent an important growth engine for Cynosure, as reflected in the 70 percent increase we achieved in international laser revenue in the first quarter of this year," said President and Chief Executive Officer Michael Davin.  "Securing additional product approvals outside of North America is one of the strategic objectives we have established for 2010.  With these clearances in Asia and South America the year is off to a strong start.  We continue to build a successful sales and marketing presence overseas, and based on the reception to our products we are enthusiastic about the potential of our international business as we move ahead."